MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Profiling the Non Motor Symptoms burden in Parkinson’s disease patients in Nigeria

T. Farombi, A. Ogunniyi (Ibadan, Nigeria)

Meeting: 2017 International Congress

Abstract Number: 67

Keywords: Non-motor Scales, Parkinsonism

Session Information

Date: Monday, June 5, 2017

Session Title: Parkinson's Disease: Non-Motor Symptoms

Session Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Objective: To determine the frequency of Non- motor symptoms (NMS) burden using the non-motor symptoms questionnaire (NMSQuest).

Background: Over the years, motor manifestations were more associated with Parkinson’s disease (PD) with little or no mention of non-motor components. There is emerging evidence that non-motor symptoms (NMS) present earlier and they are associated with quality of life of individuals. The NMS burden poses a greater care challenge to both the health workers and the caregivers.

Methods: This is a cross sectional study of PD patients on NMS longitudinal Natural Histories study. Specifically, the data of 61 consecutive PD patients that completed NMS questionnaire were analyzed using SPSS software.  

Results: Of the 61 subjects most were males 44 (72.1%) while 17 (27.9%) were females. The mean age of respondents were 68.3 (9.6) and ranged from 39-82 years.. The mean NMSQuest score among respondents were 12.8 (5.2). Most of the respondents had NMS burden 2(55.7%) followed by NMS burden 3(31.2%) and NMS burden 4(13.1%). A higher proportion of respondents with HY stage 1 had disease burden NMS 2 (71.4%) compared to those with NMS 3 (28.6%) and none had NMS 4. Those with H and Y stage 2 had a higher proportion with disease burden NMS 2 (78.4%) compared to those with NMS 3 (13.5%), and NMS 4 (8.1). For those with H and Y stage 3, a higher proportion had disease burden with NMS 3 (66.7%) compared to NMS 4 (33.3%), and none had NMS 2. All respondents with HY stage 4 had NMS 3. This difference was statistically significant with Chi square=32.579 and p value <0.001.

Fig 1: Distribution of non-motor burden and motor stage in Parkinson disease

Fig 2: Mean NMSQuest score by HY stage of disease

Conclusions: This shows that NMSQuest could be a useful tool to screen for NMS burden among PD patients especially in resource poor countries and this can be used to tailor specific treatment for individual patient during clinic visits.

References:

  1. The burden of non-motor symptoms in Parkinson’s disease using a self-completed non-motor questionnaire: A simple grading system

    Chaudhuri, K. Ray et al.

    Parkinsonism & Related Disorders , Volume 21 , Issue 3 , 287 – 291

To cite this abstract in AMA style:

T. Farombi, A. Ogunniyi. Profiling the Non Motor Symptoms burden in Parkinson’s disease patients in Nigeria [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/profiling-the-non-motor-symptoms-burden-in-parkinsons-disease-patients-in-nigeria/. Accessed May 16, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/profiling-the-non-motor-symptoms-burden-in-parkinsons-disease-patients-in-nigeria/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley